Michael Hennig

Global Head of Discovery Technologies (DT)

Back to Speakers

• Drug discovery research manager with 20 years of experience in pharmaceutical industry at Roche, Basel, Switzerland
• Co-founder and CEO of leadXpro, a spin-out of the Paul Scherrer Institute (ETH, Switzerland) dedicated to structure based drug discovery of membrane protein targets
• Formerly at Roche research Basel, Global Head and Principle Leader of discovery technologies with responsibility for structure based drug discovery, protein science, assay development and HTS, corporate compound library, stem cell platform
• Guest Professor at the University of Basel in structural biology, lecture series in pharmacy, author of >70 paper and lecturer at conferences, 8 patents in areas of technology, discovery and formulation of drug substances
• Study of physics, biochemistry, PhD in structural biology at EMBL Hamburg, Germany, postdoc at Biozentrum, University of Basel, Switzerland